Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01559805 · ClinicalTrials.gov registry record · NA

Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
202
Enrollment target

NCT01559805: Completed NA study, sponsored by Columbia University.

NCT01559805 is a NA study that has completed, run by Columbia University. The registered enrollment target is 202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01559805, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
202 participants
Enrollment target

Study Summary

The study involves delivering one of two interventions - either Promoting Action Towards Health (PATH) or Personalized Cognitive Counseling (PCC) - to 440 men who have sex with men (MSM) who have recently been diagnosed with HIV and assessing whether participants who received PATH achieve greater suppression of HIV viral load, demonstrate greater uptake of care and adherence to treatment, and engage in less sexual HIV transmission risk behavior than participants who received PCC. * PATH consists of two preliminary sessions plus "booster" sessions after 1, 3, and 6 months. * Personalized Cognitive Counseling consists of one session. Participants will complete assessments before participating in their intervention (i.e., at "baseline") and at 3, 6, 9, and 12 month follow-up points. Participants' viral loads will be measured at approximately 6 and 12 months following baseline.

Interventions

  • BEHAVIORAL Positive Choices
  • BEHAVIORAL Personalized Cognitive Counseling

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2012-11
Est. Completion 2021-12-14
Phase NA
Columbia University

958 total trials

What the finished NCT01559805 record still lists

NCT01559805 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Positive Choices is the first listed.

NCT01559805 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01559805 about?

NCT01559805 is a clinical study titled "Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men". The study involves delivering one of two interventions - either Promoting Action Towards Health (PATH) or Personalized Cognitive Counseling (PCC) - to 440 men who have sex with men (MSM) who have recently been diagnosed with HIV and assessing whether participants who received PATH achieve greater su...

What is the current status of trial NCT01559805?

This trial is currently completed. It is a NA study. The enrollment target is 202 participants. The study started on 2012-11. Estimated completion is 2021-12-14.

What interventions are being tested in trial NCT01559805?

The interventions under investigation include: Positive Choices (BEHAVIORAL), Personalized Cognitive Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01559805?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01559805's enrollment target sits among peer trials

202 505th of 2000 higher than 1,495 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01559805, the US trial registry maintained by the National Library of Medicine. NCT01559805 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.